BioCentury
ARTICLE | Clinical News

PCV7: Phase III data

July 13, 2009 7:00 AM UTC

Wyeth (NYSE:WYE), Madison, N.J. Product: PCV7 ( Prevnar) Business: Infectious Molecular target: Not applicable Description: Heptavalent pneumococcal conjugate vaccine Indication: Prevent invasive pne...